2016-03-08T00:00:00.000-05:00
Edward Kaye,0.285133
strategic plan,0.536429
research activities,0.236316
innovative RNA-targeted therapeutics,0.361593
formal notification,-0.47306
Advisory Committee Meeting,-0.47306
Massachusetts,0.518164
Central Nervous,-0.47306
rescheduled date,-0.47306
consolidation efforts,-0.267452
operational efficiency,0.536429
Sarepta Therapeutics,-0.47306
Sarepta facilities,0.236316
